ArticleApplied biochemistry and biotechnology2026

DIP2B as a Prognostic Biomarker and Immunotherapy Target: Insights from Pan-Cancer Analysis.

Hai Bai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.